ABSTRACT
Background Research is limited in comparing the analgesic efficacy of the various types of blocks with one another for hip fracture surgeries. Due to the rapid pace in the development of these new techniques in blocking the lumbar plexus and its terminal branches, uncertainty exists in literature and in practice regarding the definition and efficacy of one technique in comparison to another.
Objectives (1) To write a narrative description of regional anesthesia approaches to the lumbar plexus and associated terminal branches; (2) To do a systematic review and meta-analysis of published articles regarding the analgesic efficacy of regional anesthesia in the context of hip fracture and hip fracture surgery.
Questions (1) Does regional anesthesia of the lumbar plexus and its terminal branches enhance analgesic outcomes following hip fracture and hip fracture surgery? (2) Does the evidence point toward one techniques superiority over another? (3) Does evidence show a necessity for a nerve block over the use of opioid analgesics?
Search methods Six databases: EMBASE, PUBMED, SCOPUS, EBSCO (CINAHL and MEDLINE), WEB OF SCIENCE, COCHRANE LIBRARY were searched on October 12th, 2020.
Search criteria Studies were selected based on inclusion of: Study Design: Prospective Randomized Controlled Trials (RCT), Population: Adults (18+ years) undergoing hip fracture surgery, Intervention: FNB, FICB, PCB and/or PENG block, Comparison: Another intervention of interest, Placebo, Non-intervention, Systemic analgesics (Opioids, NSAIDs, Paracetamol), Outcome: Analgesic efficacy (Pain scores measured by Numeric Pain Rating Scale (NRS) or Visual Analogue Scale (VAS)). Studies were excluded if: Unavailable in full-text, non-human studies, Not RCT, Surgery unrelated to hip fracture.
Data collection and analysis Two reviewers extracted all relevant data from the full text versions of eligible studies using a predefined data extraction form. Study characteristics included: author, publication year, study design, sample size, inclusion and exclusion criteria, type of intervention and control, statistical analysis, outcome data, and authors’ main conclusions.
Risk of bias in individual studies assessed by two reviewers based on criteria adapted from the Cochrane ‘Risk of Bias’ assessment tool. High-risk studies were excluded.
Main results 1. FICB vs Opioid: pain scores at rest at 24h were lower in the FICB group (-0.79 [-1.34, - 0.24], P= 0.005). Pain scores on movement at 12h were lower in the FICB group (-1.91 [-2.5, -1.3], P<0.00001). No difference between groups in other times. 2. FNB vs Opioid: Initial pain scores at rest were lower in FNB (-0.58 [-0.104, -0.12], P=0.01). 3. FICB vs FNB: No difference between groups at rest. Pain scores on movement: initial scores following block, and at 24 hours were lower in the FNB group (initial: 0.53 [0.21, 0.86], P=0.001, 24 h: 0.61 [0.29, 0.94], P=0.0002, results not estimable for 12h (not enough data)).
Authors’ conclusions Both femoral nerve block and fascia iliaca compartment block enhance analgesic outcomes following hip fracture and hip fracture surgery, superior to the use of systemic analgesics such as opioids. FNB may be more efficacious at reducing pain following hip fracture surgery when compared to FICB.
INTRODUCTION
Description of the condition
Hip fractures are a common occurrence in elderly patients with multiple comorbidities such as hypertension, diabetes mellitus, cardiovascular disease, and more. Consequently, elderly patients are usually on long-term medications, which result in hemodynamic instability that complicates the perioperative management of hip-fracture patients. Unfortunately, there is high morbidity and mortality among these patients, and they are often undertreated for pain. Due to physiological frailty, medical comorbidities and cognitive impairment interfering with pain assessment and treatment, pain management in the elderly is challenging,[1].
Description of the intervention
Opioids, along with other multimodal techniques, are commonly used to address pain. However due to altered pharmacodynamics and coexisting medical conditions, elderly patients are vulnerable to the side effects of opioids such as respiratory depression[2].
The use of peripheral nerve blockade for pain management may resolve some of the issues surrounding the use of opioid analgesics in the elderly. Targeted somatic nerve block via regional anesthesia provides rapid-onset, site specific analgesia while preventing dispensable sympathetic block even in CVS compromised patients[3].
In 1884, the first clinical locoregional anesthetic technique was introduced,[4] followed by the first central neuraxis block just 5 years later. After another 7 decades, the first proximal lower extremity peripheral nerve block was described in 1973 called the “3-in-1 block,”[4]. Since then, many techniques for regional anesthesia of the lumbar plexus and its terminal branches have evolved; including psoas compartment block (PCB) (posterior lumbar plexus block), Fascia iliaca compartment block (FICB), 3-in-1 femoral nerve block (FNB) (anterior lumbar plexus block), PENG (pericapsular nerve group) block, etc. These techniques are frequently used for hip fracture patients due to the opioid-sparing effects,[5].
How the intervention might work
The lumbar plexus is formed by lumbar nerves L1-L4 and is the origin of the ilioinguinal and iliohypogastric nerves, as well as the 4 major nerves that supply the lower limb: femoral, lateral femoral cutaneous, obturator, and genitofemoral. The plexus is formed lateral to the intervertebral foramina and passes through psoas major. The nerves of the lumbar plexus pass in front of the hip joint and mainly support the anterior part of the thigh[7].
Regional anaesthesia provides analgesia by pharmacologic disruption of nociceptive transmission, neuroanatomy of the injury, anatomical target sites. Analgesia of large parts of the leg can be achieved by blocking the lumbar plexus and its associated terminal branches. Thus, it is principally used for post-operative analgesia for hip surgeries[8] and provide opioid-sparing effects[9].
A timeline and description of regional anaesthesia approaches to the lumbar plexus and associated terminal branches is provided in Appendix A.
Why it is important to do this review
Early surgery within 48 hours of the hip fracture has shown to decrease complication and mortality rates[6]. This gives an opportunity for anesthesiologists to offer regional analgesia for effective pain control. However, due to the rapid pace in the development of these new techniques in blocking the lumbar plexus and its terminal branches, confusion exists in literature and in practice regarding the definition and efficacy of one technique in comparison to another.
Objectives
(1) To write a narrative description of regional anesthesia approaches to the lumbar plexus and associated terminal branches; (2) To do a systematic review and meta-analysis of published articles regarding the analgesic efficacy of regional anesthesia in the context of hip fracture and hip fracture surgery, to answer the following questions: (1) Does regional anesthesia of the lumbar plexus and its terminal branches enhance analgesic outcomes following hip fracture and hip fracture surgery? (2) Does the evidence point toward one techniques superiority over another? (3) Does evidence show a necessity for a nerve block over the use of opioid analgesics?
METHODS
Criteria for considering studies for this review
Types of studies
Only prospective RCTs were included in this study, including no blinding, single-blinded and double-blinded studies.
Types of participants
Adults (18+ years) undergoing hip fracture surgery.
Outcome: Analgesic efficacy (Pain scores measured by Visual analogue scale (VAS) or Numerical rating scale (NRS)). Studies were excluded if: Unavailable in full-text, non-human studies, Not RCT, Surgery unrelated to hip fracture.
Types of interventions
FNB, FICB, PCB and/or PENG block compared to another intervention of interest, placebo, non-intervention, or systemic analgesics (opioids, NSAIDs, paracetamol). Any dose or form of local anesthetic to accompany technique (including continuous catheter infusion or single dose) were included.
Types of outcome measures
Primary outcomes
Analgesic efficacy of the intervention using VAS or NRS scales.
Secondary outcomes
Other outcomes were accounted for but not included in the meta-analysis, such as: pre-operative and/or post-operative need for analgesia, time to first request for additional analgesia, adverse effects, allergic reactions, length of hospital stay, mortality.
Search methods for identification of studies
Electronic searches
Both electronic and hand-searching techniques were used to identify studies. Six databases: EMBASE, PUBMED, SCOPUS, EBSCO (CINAHL and MEDLINE), WEB OF SCIENCE, COCHRANE LIBRARY were searched on October 12th, 2020.
Searches were limited based on inclusion criteria:
Type of block: Femoral nerve block, Fascia iliaca compartment block, Psoas compartment block, Lumbar plexus block, Pericapsular nerve group PENG block
Type of study: Randomized controlled trial, Human study, Available in English
Age: Adult (18+)
Search words for each database are summarized in Appendix B.
Searching other resources
Manual searches were then conducted for all eligible articles via their reference list and related articles suggested by PubMed.
Data collection and analysis
Two reviewers extracted all relevant data from the full text versions of eligible studies using a predefined data extraction form. Study characteristics included: author, publication year, study design, sample size, inclusion and exclusion criteria, type of intervention and control, statistical analysis, outcome data, and authors’ main conclusions.
Selection of studies
The abstract of each study was reviewed for eligibility by one reviewer (A.M.S). Potential studies underwent full text review by the same author. Studies were excluded if they did not meet the inclusion criteria. The inclusion and exclusion criteria are outlined in Appendix C.
Assessment of risk of bias in included studies
Risk of bias in individual studies assessed by two reviewers based on criteria adapted from the Cochrane ‘Risk of Bias’ assessment tool (RoB 2). A study was rated overall as Low risk, Some concerns, or High risk for bias based on five domains: (1) Randomisation process, (2) Deviations from intended interventions, (3) Missing outcome data, (4) Measurement of the outcome, (5) Selection of the reported result. High risk of bias determined by important imbalances at baseline, improper randomisation, failure of blinding of outcome assessors and significant (>15%) loss to follow-up. High-risk studies were excluded.
Unit of analysis issues
The Hozo equation (Hozo) was used to derive mean and standard deviation from median and inter-quantile ranges. For sample sizes greater than 25, the sample’s median was set to equal to mean as recommended by Hozo et al. Also, for sample sizes of 15 through 70, range was divided by 4 as the best estimate of the sample’s standard deviation as recommended by Hozo et al. The 11-point NRS, and 100-mm VAS scores divided by 10 were considered equal to the 10-cm VAS scale. Point estimates and 95% confidence intervals (CIs) of individual included studies and results were shown via forest plots. Data analyses abided by the guidelines set out by the Cochrane Collaboration regarding statistical methods. two-tailed P-values <0.05 were considered significant in all instances. Relative risks and the standardised mean difference (SMD) for continuous outcomes were also calculated.
Dealing with missing data
Authors of included studies were individually contacted for missing data.
Assessment of heterogeneity
Chi-squared statistic was used to assess heterogeneity, where values >50% are consistent with large heterogeneity, and using heterogeneity P-value, where values <10% are consistent with large heterogeneity.
Assessment of reporting biases
Funnel plots were conducted to detect publication bias.
Subgroup analysis and investigation of heterogeneity
Since heterogeneity was expected across studies, an inverse variance random-effects model was used to evaluate outcomes. Heterogeneous control interventions and data collection points were investigated via subgroup analyses. Intervention types were pooled into the following subgroups; (1) Fascia-iliaca compartment block vs. intra-articular hip injection (2) Fascia-iliaca compartment block vs. Placebo (sham block) (3) Fascia iliaca compartment block vs. Femoral nerve block (4) Fascia iliaca compartment block vs. opioid or other analgesic (5) Femoral nerve block vs. Placebo (sham block) (6) Femoral nerve block vs. opioid or other analgesic.
Sensitivity analysis
All analyses were conducted using Review Manager (RevMan; version 5.4).
A flow chart demonstrating an overview of the research protocol and study selection process can be found in Appendix D.
RESULTS
Description of the studies
Results of the search
The database search yielded 439 studies. A total of 316 abstracts were screened after removal of duplicates. After screening, 70 full text articles were assessed for eligibility.
Included studies
In total, twenty-five studies met the inclusion criteria[12, 14, 16, 20, 23, 27, 28, 33, 34, 38, 47, 51, 59, 60, 62, 65, 57, 66, 74, 77, 80, 82, 83, 85, 86]. Included studies date from 2007 to 2019.
Five articles were removed due to high risk of bias[27, 33, 51, 74, 80], leaving twenty studies for the meta-analysis. The twenty studies yielded 1871 patients in total, with 937 total patients in the intervention groups, and 934 total patients in the control groups.
Excluded studies
Eight studies were removed because the research was not yet complete[17, 18, 53-58], 20 studies were removed because they were irrelevant to hip fracture[10, 13, 15, 22, 24, 26, 29-32, 39, 41, 43, 45, 63, 68, 69-71, 73], six studies were removed because their outcomes did not focus on analgesic efficacy[11, 40, 52, 64, 78, 79], two studies were unavailable in full text (19, 75), and lastly, 9 articles were removed due to inappropriate study design[25, 35, 36, 42, 44, 49, 50, 67, 84]. The reference lists of all articles examined by full text and similar reviews were hand searched, but yielded no additional articles.
Study characteristics
Table 1 presents highlighted study features. All twenty studies were randomised controlled trials. Seven studies compared FICB with opioids[28, 47, 60, 62, 82, 83, 85]. Seven studies compared FNB with opioids[14, 16, 34, 38, 66, 72, 77]. Five studies compared FNB with FICB [20, 23, 59, 65, 86]. One study compared FICB with intra-articular hip injection[12]. See Table 1.
Study characteristics for all included studies in this review. (FICB, fascia iliaca compartment block; FNB, femoral nerve block; NRS, numeric rating scale; VAS, visual analogue scale; RCT, randomized controlled trial; US, ultrasound).
Risk of bias in included studies
Based on criteria adapted from the Cochrane ‘Risk of Bias’ assessment tool, nine of the included randomised controlled trials[12, 16, 38, 47, 62, 65, 82, 85, 86] were rated with overall low risk of bias, eleven studies had some concerns according to RoB 2[14, 20, 23, 28, 34, 59, 60, 66, 72, 77, 83], and five studies were rated as high risk of bias[27, 33, 51, 74, 80]. These findings are summarized in Table 2. Of the papers with some concern for risk of bias, five had issues with the randomisation process[14, 20, 23, 28, 77], two had deviations from the intended interventions[14, 57], eight had issues with measurement of the outcome[23, 34, 59, 60, 66, 72, 77, 83]. Of the papers with high risk of bias, three had issues with; the (i) randomization process, had (ii) deviations from the intended interventions, and had issues with the (iii) outcome measurement[27, 74, 80], one had issues with the randomization process and measurement of the outcome[33], and one had deviations from the intended interventions as well as issues with the measurement of outcome[51]. None of the papers had missing outcome data, loss to follow-up >15%. or issues with selection of the reported result. The five papers with high risk of bias according to the RoB 2 tool were excluded from the meta-analysis. Thus, twenty articles were included in the meta-analysis.
Risk of bias within studies based on criteria adapted from the Cochrane ’Risk of Bias’ assessment tool.
Results of individual studies
In the meta-analysis of the seven studies comparing the analgesic efficacy of FICB compared with Opioids, there was a statistically significant difference between the groups at rest at 24 hours and on movement at 12 hours as shown in Table 3. Data for pain scores at rest at 24 hours in this group were derived from three studies out of the seven as shown in Figure 1. Compared with opioids at rest at 24 hours, FICB had a greater analgesic effect with an SMD (standardized mean difference) of -0.79 (95% CI; -1.34, -0.24) (P = 0.005) (Z = 2.83) (heterogeneity: tau2 = 0.09, Chi2 = 3.23, df = 2, P = 0.20, I2 = 38%). Data for pain scores on movement at 12 hours in this group were derived from two studies out of the seven as shown in Figure 2. Compared with opioids on movement at 12 hours, FICB had a greater analgesic effect with an SMD (standardized mean difference) of -1.91 (95% CI; -2.52, -1.30) (P < 0.00001) (Z = 6.18) (heterogeneity: tau2 = 0.00, Chi2 = 1.00, df = 1, P = 0.32, I2 = 0%).
Forest plot of comparison: FICB vs. Opioids. Outcome: pain scores at rest at 24 hours.
Forest plot of comparison: FICB vs. Opioids. Outcome: pain scores on movement at 12 hours.
Fascia iliaca compartment block vs. Opioids
In the meta-analysis of the seven studies comparing the analgesic efficacy of FNB compared with Opioids, there was a statistically significant difference between the groups initially at rest following the block as shown in Table 4. Data for pain scores at rest following the block in this group were derived from five studies out of the seven as shown in Figure 3. Compared with opioids at rest following the block, FICB had a greater analgesic effect with an SMD (standardized mean difference) of -0.58 (95% CI; -1.04, -0.12) (P = 0.01) (Z = 2.49) (heterogeneity: tau2 = 0.19, Chi2 = 16.46, df = 4, P = 0.002, I2 = 76%).
Forest plot comparison: FNB vs. Opioids. Outcome: initial pain scores at rest following block.
Femoral nerve block vs. Opioids
In the meta-analysis of the five studies comparing the analgesic efficacy of FICB compared with FNB, there was a statistically significant difference between the groups on movement initially following the block and on movement at 24 hours as shown in Table 5. Data for pain scores on movement initially following the block in this group were derived from one study out of the five as shown in Figure 4. Compared with FICB on movement initially following the block, FNB had a greater analgesic effect with an SMD (standardized mean difference) of 0.53 (95% CI; 0.21, 0.86) (P = 0.001) (Z = 3.26) (heterogeneity: not applicable). Data for pain scores on movement at 24 hours in this group were derived from one study out of the five as shown in Figure 5. Compared with FICB on movement at 24 hours, FNB had a greater analgesic effect with an SMD (standardized mean difference) of 0.61 (95% CI; 0.29, 0.94) (P < 0.002) (Z = 3.71) (heterogeneity: not applicable).
Forest plot comparison: FICB vs. FNB. Outcome: initial pain scores on movement following block.
Forest plot of comparison: FICB vs. FNB. Outcome: pain scores on movement at 24 hours.
Fascia iliaca compartment block vs. Femoral nerve block
Forest plots for the studies with statistically significant findings can be found in Figures 6-9.
Funnel plot of comparison: FICB vs. Opioids. Outcome: pain scores at rest at 24 hours.
Funnel plot of comparison: FICB vs. Opioids. Outcome: pain scores on movement at 12 hours.
Funnel plot of comparison: FNB vs. Opioids. Outcome: initial pain scores at rest following block.
Funnel plot comparison: FICB vs. FNB. Outcome: initial pain scores on movement following block.
Funnel plot of comparison: FICB vs. FNB Outcome: pain scores on movement at 24 hours
DISCUSSION
Summary of main results
This systematic review and meta-analysis demonstrated that FNB had a superior analgesic effect compared with FICB, and both FNB and FICB had superior analgesic effect compared with opioids.
Of the twenty studies included in the meta-analysis, 7 studies compared FICB with opioids. Pain scores at rest at 24 hours (-0.79 [-1.34, -0.24], P= 0.005), and on movement at 12 hours post hip-fracture surgery (-1.91 [-2.5, -1.3], P< 0.00001) were lower in the FICB group compared with the opioid group. However, there was no statistically significant difference between the use of FICB versus opioids in analgesic efficacy measured by pain (VAS, NRS) scores after hip fracture surgery in patients initially at rest following the block, at rest at 12 hours, initial pain scores on movement following the block, or on movement at 24 hours.
An additional seven studies compared FNB with opioids. The initial pain scores at rest were lower in the FNB group (-0.58 [-0.104, -0.12], P= 0.01). However, there was no statistically significant difference between the use of FNB versus opioids in analgesic efficacy after hip fracture surgery in patients at rest at 12 hours, 24 hours, or when comparing initial pain scores on movement following the block. There was insufficient data for pain scores on movement at 12 hours, and 24 hours.
Finally, five studies compared FNB with FICB. Pain scores on movement initially following the block, and at 24 hours were lower in the FNB group when compared with FICB (initial: 0.53 [0.21, 0.86], P= 0.001, 24 h: 0.61 [0.29, 0.94], P= 0.0002). However, there was no statistically significant difference between the groups for pain scores at rest. There was insufficient data for pain scores at rest at 12 hours, and pain scores on movement at 12 hours.
The remaining study compared the analgesic efficacy of FICB with intra-articular hip injection (IAHI) as control[12]. The primary outcome was pain relief measured using the NRS at 20 minutes, 12 hours, 24 hours and 48 hours after the regional anaesthesia, both at rest and on movement. Pain was significantly lower in the IAHI group during movement of the fractured limb at 20 min (p < 0.05), 12h (p<0.05), 24h (p<0.05) and 48h (p<0.05). the findings of this study suggest that IAHI provides better pre-operative pain management in elder patients with intracapsular hip fractures compared to FICB.
Strengths and Limitations
The strengths of this study are that two independent reviewers decided the eligibility of the full-text articles and conducted the risk of bias assessment, and high risk of bias papers were not included in the meta-analysis. In addition, a full manual search was conducted to ensure no missing articles, and authors of the included papers were contacted for missing data. However, the limitations of this study were that filters were applied during the search, which set limits for the type of study, age, language, etc. Due to subgrouping, there were not enough studies to conduct funnel plots and rule out publication bias. The funnel plot might appear symmetrical, but the interpretation is unsure, with only five to seven studies per subgroup. In addition, the statistically significant results for the FICB vs. FNB subgroup were based on data from 1 paper.
AUTHORS’ CONCLUSIONS
Implications for practice
Both femoral nerve block and fascia iliaca compartment block enhance analgesic outcomes following hip fracture and hip fracture surgery, superior to the use of systemic analgesics such as opioids. FNB may be more efficacious at reducing pain following hip fracture surgery when compared to FICB.
Implications for research
This paper was designed to include all forms of regional anaesthesia for the lumbar plexus and its terminal branches. In the end, there was only enough high quality randomized-controlled trials to answer the research questions for Femoral nerve block and Fascia Iliaca Compartment block. More research should be conducted on the analgesic efficacy of PCB and PENG block for hip fracture surgeries. That way, future systematic reviews and meta-analyses can effectively compare all the block types. Future studies should further focus on comparing the analgesic efficacy of FNB vs FICB with respect to hip fracture surgeries to see if evidence supports the superiority of FNB compared to FICB.
CONTRIBUTIONS OF AUTHORS
Conducted literature search and study selection: A.M.S.
Supervised literature search and study selection: B.O.D.
Performed data extraction and assessment of risk of bias: both authors.
Conducted meta-analysis: A.M.S.
Supervised meta-analysis: B.O.D.
Wrote manuscript: A.M.S.
DECLARATIONS OF INTEREST
The authors have no competing interest to declare.
DIFFERENCES BETWEEN PROTOCOL AND REVIEW
There were no differences between the protocol and review.
Data Availability
All data produced in the present work are contained in the manuscript
APPENDIX
Timeline and description of regional anaesthesia approaches to the lumbar plexus and associated terminal branches.
Database search words and results.
Inclusion and exclusion criteria used to select articles.
Overview of research protocol and study selection process.
completed checklist for the reporting guideline appropriate to study: PRISMA 2020 Checklist from www.equator-network.org
ACKNOWLEDGMENT
I would like to thank Dr. Brian O’Donnell for his contributions and guidance throughout this project.
Footnotes
Conflicts of Interest: The authors declare no conflicts of interest [or state specific conflicts].
Funding: The authors have no sources of funding to declare for this manuscript [or declare funding].
REFERENCES
- 1.↵
- 2.↵
- 3.↵
- 4.↵
- 5.↵
- 6.↵
- 7.↵
- 8.↵
- 9.↵
- 10.↵
- 11.↵
- 12.↵
- 13.↵
- 14.↵
- 15.↵
- 16.↵
- 17.↵
- 18.↵
- 19.
- 20.↵
- 21.
- 22.↵
- 23.↵
- 24.↵
- 25.↵
- 26.↵
- 27.↵
- 28.↵
- 29.↵
- 30.
- 31.
- 32.↵
- 33.↵
- 34.↵
- 35.↵
- 36.↵
- 37.
- 38.↵
- 39.↵
- 40.↵
- 41.↵
- 42.↵
- 43.↵
- 44.↵
- 45.↵
- 46.
- 47.↵
- 48.
- 49.↵
- 50.↵
- 51.↵
- 52.↵
- 53.↵
- 54.
- 55.
- 56.
- 57.↵
- 58.↵
- 59.↵
- 60.↵
- 61.
- 62.↵
- 63.↵
- 64.↵
- 65.↵
- 66.↵
- 67.↵
- 68.↵
- 69.↵
- 70.
- 71.↵
- 72.↵
- 73.↵
- 74.↵
- 75.
- 76.
- 77.↵
- 78.↵
- 79.↵
- 80.↵
- 81.
- 82.↵
- 83.↵
- 84.↵
- 85.↵
- 86.↵
- 87.
- 88.
- 89.
- 90.
- 91.
- 92.
- 93.
- 94.